Status epilepticus: Why, what, and how

Journal of Postgraduate Medicine

Volumn 57, Issue 3, 2011, Pages 242-252

  Nair, P P ^a   Kalita, J ^a   Misra, U K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Electroencephalography; Etiology; Status epilepticus; Treatment

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PROPYLENE GLYCOL; THIAMINE; THIOPENTAL; VALPROIC ACID;

ACIDOSIS; ALCOHOL INTOXICATION; BLOOD PRESSURE; BRAIN; CENTRAL NERVOUS SYSTEM INFECTION; COMA; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; ELECTROENCEPHALOGRAPHY; EMERGENCY CARE; EPILEPTIC STATE; FLUID RESUSCITATION; GENETIC ANALYSIS; GROUPS BY AGE; HEART; HEART ARRHYTHMIA; HISTORY OF MEDICINE; HUMAN; HYPERLIPIDEMIA; HYPERPYREXIA; HYPOGLYCEMIA; HYPOTENSION; HYPOXIA; INFANTILE SPASM; LACTIC ACIDOSIS; LANDAU KLEFFNER SYNDROME; LOADING DRUG DOSE; LUMBAR PUNCTURE; MAINTENANCE DRUG DOSE; MEDICAL HISTORY; METABOLIC DISORDER; MORBIDITY; MORTALITY; NEUROIMAGING; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PATHOPHYSIOLOGY; PROGNOSIS; RECURRENT INFECTION; REPEATED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STROKE; TONIC CLONIC SEIZURE; TOXICITY TESTING; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; WERNICKE ENCEPHALOPATHY;

ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; HUMANS; STATUS EPILEPTICUS;

EID: 80054028164     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.81807     Document Type: Review

References (134)

1. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50:735-45
2. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective ,population based epidemiologic study of status epilepticus in Richmond,Virginia. Neurology 1996;46:1029-35 (Pubitemid 26134646)
3. Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French speaking Switzerland. Neurology 2000;55:693-7
4. Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, et al. Status Epilepticus Study Group Hessen (SESGH). Incidence of status epilepticus in adults in Germany: A prospective, populationbased study. Epilepsia 2001;42:714-8.
5. Vignatelli L, Tonon C, D'Alessandro R; Bologna Group for the Study of Status Epilepticus. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003;44:964-8. (Pubitemid 36842188)
6. Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007;6:329-39. (Pubitemid 46367947)
7. Walker MC. The epidemiology and management of status epilepticus. Curr Opin Neurol 1998;11:149-54. (Pubitemid 28159701)
8. Kalita J, Nair PP, Misra UK. A clinical, radiological and outcome study of status epilepticus from India. J Neurol 2010;257:224-9.
9. DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-40. (Pubitemid 128721651)
10. Narayanan JT, Murthy JM. Nonconvulsive status epilepticus in a neurological intensive care unit: profile in a developing country. Epilepsia 2007;48:900-6. (Pubitemid 46763419)
11. Wilson JV, Reynolds EH. Texts and documents.Translation and analysis of a cuneiform text forming part of Babylon treatise on epilepsy. Med Hist 1990;34:185-98.
12. Bourneville DM.Recherches cliniques et therapeutiques sur l'epilepsie et l' hysterie Paris: Dilahaye,1876.
13. Clark L, Prout T. Status epilepticus A clinical and pathological study in epilepsy .Am J Insanity 1903;60:291-306.
14. Wilson S. Neurology. Baltimore Williams and Wilkins ,1940
15. Commision on international classification of epileptic seizures. A proposed international classification of epileptic seizures. Epilepsia 1964;5:297-306.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
17. Sarice Bassin ,Teresa L Smith , Thomas P Bleck clinical review: Status Epilepticus critical care 2002;6:137-42.
18. Nevander G, Ingvar M, Auer R, Siesjo BK. Status epilepticus in well oxygenated rats causes neuronal necrosis. Ann Neurol 1985;18:281-90. (Pubitemid 15023100)
19. Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol 1973;28:1-9.
20. Lothman E. Biochemical basis and pathophysiology of status epilepticus. Neurology 1990;40:13-23.
21. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-22 (Pubitemid 29031765)
22. Bleck T. Convulsive disorders. Status epilepticus. Clin Neuropharmacol 1991;14:191-198.
23. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, et al. The secondarily generalized tonic clonic seizure: A video tape analysis. Neurology 1994;44:1403-7.
24. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7.
25. Gastaut H, Broughton R. Epileptic seizures: Clinical and Electrographic features, diagnosis and treatment Springfield. IL:Charles C.Thomas1972:25-90.
26. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for genetalized convulsive status epilepticus. N Engl J Med 1998;339:792-8. (Pubitemid 28447452)
27. DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 1999;40:164-9. (Pubitemid 29066300)
28. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
29. Shorvon S. Status epilepticus:It's clinical features and treatment in children and adults.Cambridge,UK:Cambridge University Press 1994.
30. Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 2005;7:253-96. (Pubitemid 41392426)
31. Peter W. Kaplan The EEG of status epilepticus. J Clin Neurophysiol 2006;23:221-9.
32. Lothman EW, Bertram EH 3rd, Stringer JL. Functional anatomy of hippocampal seizures. Prog Neurobiol 1991;37:1-82.
33. Perl TM, Bédard L, Kosatsky T, Hockin JC, Todd EC, Remis RS. An outbreak of encephalopathy caused by eating mussels contaminated with domoic acid. N Engl J Med 1990;322:1775-80 (Pubitemid 20194656)
34. Buterbaugh GG, Michelson HB, Keyser DO. Status epilepticus facilitated by pilocarpine in amygdala-kindled rats. Exp Neurol 1986;94:91-102. (Pubitemid 16002179)
35. Morrisett RA, Jope RS, Snead OC, III. Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: Comparison with kainic acid. Exp Neurol 1987;98:594-605.
36. Suchomelova L, Baldwin RA, Kubova H, Thompson KW, Sankar R, Wasterlain CG. Treatment of experimental status epilepticus in immature rats: Dissociation between anticonvulsant and antiepileptogenic effects. Pediatr Res 2006;59:237-43. (Pubitemid 43840995)
37. Mazarati AM, Wasterlain CG, Sankar R, Shin D. Self-sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res 1998;801:251-3. (Pubitemid 28401673)
38. Lothman EW, Bertram EH, Bekenstein JW, Perlin JB. Selfsustaining limbic status epilepticus induced by 'continuous'hippocampal stimulation: Electrographic and behavioral characteristics. Epilepsy Res 1989;3:107-19. (Pubitemid 19071179)
39. Lothman EW, Bertram EH, Kapur J, Stringer JL. Recurrent spontaneous hippocampal seizures in the rat as a chronic sequel to limbic status epilepticus. Epilepsy Res 1990;6:110-8. (Pubitemid 20184977)
40. Vicedomini JP, Nadler JV. A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways. Exp Neurol 1987;96:681-91. (Pubitemid 17090774)
41. Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999;265:187-90. (Pubitemid 29207397)
42. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996;37:863-7. (Pubitemid 26313732)
43. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005;25:7724-33. (Pubitemid 41208643)
44. Naylor DE, Wasterlain CG. GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia 2005;46:142-7. (Pubitemid 40962137)
45. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179-85. (Pubitemid 29023424)
46. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997;17:7532-40. (Pubitemid 27413283)
47. Kaila K, Voipio J. Postsynaptic fall in intracellular pH induced by GABA-activated bicarbonate conductance. Nature 1987;330:163-5. (Pubitemid 17158543)
48. Staley KJ, Soldo BL, Proctor WR. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 1995;269:977-81.
49. Wasterlain CG, Liu H, Mazarati A, Balwin RA. NMDA receptor trafficking during the transition from single seizures to status epilepticus. Ann Neurol 2002;52:16.
50. Bleck TP. Refractory status epilepticus in 2001.Arch Neurol 2002;59:188-9. (Pubitemid 34240932)
51. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34:S37-53. (Pubitemid 23107999)
52. Meldrum BS, Brierly JB. Prolonged epileptic seizure in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol 1973;28:10-7.
53. Benowitz NL, Simon RP, Copeland JR. Status epilepticus: Divergence of sympathetic activity and cardiovascular response. Ann Neurol 1986;19:197-9. (Pubitemid 16114177)
54. Gravenstein JS, Anton AH, Wiener SM, Tetlow AG. Catecholamine and cardiovascular response to electroconvulsive therapy in man. Br J Anaesth 1965;37:833-9.
55. Kiessling M, Hossman KA, Kleihues P. Pulmonary edema during bicuculline-induced seizures in rats. Exp Neurol 1981;74:430-8. (Pubitemid 12231676)
56. Simon RP, Bayne LL, Tranbaugh RF, Lewis FR. Elevated pulmonary lymph flow and protein content during status epilepticus in sheep. J Appl Physiol 1982;52:91-5. (Pubitemid 12041144)
57. Oxbury JM, Whitty CW. Causes and consequences of status epilepticus in adults. A study of 86 cases. Brain 1971;94:733-44.
58. Aminoff MJ, Simon RP. Status epilegticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-66. (Pubitemid 11241340)
59. Schmidley JW, Simon RP. Postictal pleocytosis. Ann Neurol 1981;9:81-4. (Pubitemid 11217707)
60. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974;291:807-11.
61. Howse DC, Caronna JJ, Duffy TE, Plum F. Cerebral energy metabolism, pH and blood flow during seizures in the cat. Am J Physiol 1974;227:1444-5.
62. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry 2001;70 2:II22-7.
63. Kalita J, Misra UK, Patel R. Initial EEG in status epilepticus is helpful in predicting seizure recurrence. Electromyogr Clin Neurophysiol 2006;46:139-44. (Pubitemid 44082584)
64. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54:340-5. (Pubitemid 30078063)
65. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992;42:100-4.
66. Riviello JJ Jr, Ashwal S, Hirtz D, Glauser T, Ballaban-Gil K, Kelley K, et al. American Academy of Neurology Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67:1542-50. (Pubitemid 44747921)
67. Lacroix J, Deal C, Gauthier M, Rousseau E, Farrell CA. Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience. Crit Care Med 1994;22:827-32. (Pubitemid 24151077)
68. Dunn DW. Status epilepticus in children: Etiology, clinical features, and outcome. J Child Neurol 1988;3:167-73.
69. Karasalihoglu S, Oner N, Celtik C, Celik Y, Biner B, Utku U. Risk factors of status epilepticus in children. Pediatr Int 2003;45:429-34. (Pubitemid 37129931)
70. Gulati S, Kalra V, Sridhar MR. Status epilepticus in Indian children in a tertiary care center. Indian J Pediatr 2005;72:105-8. (Pubitemid 40380001)
71. Shinnar S, Kang H, Berg AT, Goldensohn ES, Hauser WA, Moshe SL. EEG abnormalities in children with a first unprovoked seizure. Epilepsia 1994;35:471-6. (Pubitemid 24217747)
72. Shinnar S, Berg AT, Moshe SL, O'Dell C, Alemany M, Newstein D, et al. The risk of seizure recurrence following a first unprovoked afebrile seizure in childhood: An extended follow-up. Pediatrics 1996;98:216-25. (Pubitemid 26262133)
73. Bernard S. Chang, Daniel H. Lowenstein Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2003;60;10-6 (Pubitemid 36070636)
74. Pakalnis A, Paolicchi J, Gilles E. Psychogenic status epilepticus in children: Psychiatric and other risk factors. Neurology 2000;54:969-70. (Pubitemid 30111360)
75. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021-7. (Pubitemid 29161614)
76. Kim JA, Chung JI, Yoon PH, Kim DI, Chung TS, Kim EJ, et al. Transient MR signal changes in patients with generalized tonic clonic seizure or status epilepticus: Periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22:1149-60.
77. Diehl B, Najm I, Ruggieri P, Foldvary N, Mohamed A, Tkach J, et al. Periictal diffusion-weighted imaging in a case of lesional epilepsy. Epilepsia 1999; 40:1667-71. (Pubitemid 29518101)
78. Szabo K, Poepel A, Pohlmann-Eden B, Hirsch J, Back T, Sedlaczek O, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 2005;128:1369-76 (Pubitemid 40826190)
79. Fabene PF, Marzola P, Sbarbati A, Bentivoglio M. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain:diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage 2003;18:375-89. (Pubitemid 36269147)
80. Phillips SA, Shanahan RJ. Etiology and mortality of status epilepticus in children: A recent update. Arch Neurol 1989;46:74-6. (Pubitemid 19022818)
81. Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure 2003;12:337-345. (Pubitemid 37062762)
82. Kwong KL, Lee SL, Yung A, Wong VC. Status epilepticus in 37 Chinese children: Aetiology and outcome. J Paediatr Child Health 1995;31:395-8.
83. Ibrahim SH, Yezdan MA, Nizami SQ. Status epilepticus in children: A five-year experience at Aga Khan University Hospital. J Pak Med Assoc 2003;53:597-9. (Pubitemid 38133281)
84. Maytal J, Novak G, Ascher C, Bienkowski R. Status epilepticus in children with epilepsy: the role of antiepileptic drug levels in prevention. Pediatrics 1996;98:1119-21. (Pubitemid 26399275)
85. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children: A study of 239 cases. Epilepsia 1970;11:187-97.
86. Tabarki B, Yacoub M, Selmi H, Oubich F, Barasaoui S, Essoussi AS. Infantile status epilepticus in Tunisia: Clinical, etiological and prognostic aspects. Seizure 2001;10:365-9. (Pubitemid 32755360)
87. Scholtes FB, Renier WO, Meinardi H. Status epilepticus in children. Seizure 1996;5:177-84. (Pubitemid 26345839)
88. Mah JK, Mah MW. Pediatric status epilepticus: A perspective from Saudi Arabia. Pediatr Neurol 1999;20:364-9. (Pubitemid 29250181)
89. Yager JY, Cheang M, Seshia SS. Status epilepticus in childhood. Can J Neurol Sci 1988;15:402-4.
90. Kwong KL, Chang K, Lam SY. Features predicting adverse outcomes of status epilepticus in childhood. Hong Kong Med J 2004;10:156-9. (Pubitemid 38788619)
91. Maegaki Y, Kurozawa Y, Hanaki K, Ohno K. Risk factors for fatality and neurological sequelae after status epilepticus in children. Neuropediatrics 2005;36:186-92. (Pubitemid 41117115)
92. Eriksson KJ, Koivikko MJ. Status epilepticus in children: Aetiology, treatment and outcome. Dev Med Child Neurol 1997;39:652-8. (Pubitemid 27421304)
93. Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: A survey of neurologists. J Neurol Sci. 2003;211:37-41. (Pubitemid 36593265)
94. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4. (Pubitemid 13158575)
95. Lowenstein DH. Status epilepticus. West J Med 1998;168:263. (Pubitemid 28198691)
96. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988;38:202-7. (Pubitemid 18036837)
97. Ramsay RE, Hammond EJ, Perchalski RJ, Wilder BJ. Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 1979;36:535-9. (Pubitemid 9231479)
98. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837-40. (Pubitemid 24319206)
99. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: A review of its pharmacological properties and therapeutic uses. Drugs 1984;28:519-43. (Pubitemid 15211797)
100. Galvin GM, Jelinek GA. Midazolam: An effective intravenous agent for seizure control. Arch Emerg Med 1987;4:169-72. (Pubitemid 18067180)
101. Ghilain S, Van Rijckevorsel-Harmant K, de Barsy TH. Midazolam in the treatment of epileptic seizures. J Neurol Neurosurg Psychiatry 1988;51:732.
102. Jawad S, Oxley J, Wilson J, Richens A. A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psychiatry 1986;49:1050-4. (Pubitemid 16012677)
103. Ramsay RE, DeToledo J. Intravenous administration of fosphenytoin: Options for the management ofseizures. Neurology. 1996;46:S17-19. (Pubitemid 26185757)
104. Eldon MA, Loewen GR, Voigtman RE, Holmes GB, Hunt TL, Sedman AJ. Pharmacokinetics and tolerance of fosphenytoin and phenytoin administered intravenously to healthy subjects. Can J Neurol Sci 1993;20:S180.
105. Boucher BA, Feler CA, Dean JC, Michie DD, Tipton BK, Smith KR Jr, et al. Pharmacotherapy. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients. Pharmacotherapy 1996;16:638-45 (Pubitemid 26285916)
106. Leppik IE, Boucher R, Wilder BJ, Murthy VS, Rask CA, Watridge C, et al. Phenytoin prodrug: Preclinical and clinical studies. Epilepsia 1989;30 Suppl 2:S22-6. (Pubitemid 19231524)
107. Uthman BM, Wilder BJ, Ramsay RE. Intramuscular use of fosphenytoin: An overview. Neurology 1996;46:S24-8. (Pubitemid 26185759)
108. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: A pilot study. Neurology 2006;67:340-2. (Pubitemid 44313586)
109. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004;63:1507-8. (Pubitemid 39426292)
110. Koren G, Butt W, Rajchgot P, Mayer J, Whyte H, Pape K, et al. Intravenous paraldehyde for seizure control in newborn infants. Neurology 1986;36:108-11. (Pubitemid 16186064)
111. Browne TR. Paraldehyde, Chlormethiazole, and Lidocaine for treatment of status epilepticus. In: Delgado Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, eds. Status epilepticus: mechanisms of brain damage and treatment. Advances in neurology, vol 34.New York: Raven Press, 1983:509-517.
112. Lockman LA. Paraldehyde. In: Levy RH, Dreifuss FE,Mattson RH, Meldrum BS, Penry JK, eds. Antiepileptic Drugs, 3rd ed. New York: Raven Press, 1989:881-886.
113. Partinen M, Kovanen J, Nilsson E. Status epilepticus treated with barbiturate anaesthesia with continuous monitoring of cerebral function. Br Med J 1981;282:520-1. (Pubitemid 11188763)
114. Young EB, Blume WT, Bolton CF, Warren KG. Anesthetic barbiturates in refractory status epilepticus. Can J Neurol Sci 1980;7:291-2. (Pubitemid 11205132)
115. Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984;12:367-72. (Pubitemid 14135830)
116. Lowenstein DH, Aminoff MJ, Simon RJ. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience of 14 patients. Neurology 1988;38:395-400. (Pubitemid 18083675)
117. MacKenzie SJ, Kapadia F, Grant IS. Propofol infusion for control of status epilepticus. Anaesthesia 1990;45:1043-5.
118. Alia G, Natale E, Mattaliano A, Daniele O. On two cases of status epilepticus treated with propofol. Epilepsia 1991;32:77.
119. Wood PR, Browne GP, Pugh S. Propofol infusion for the treatment of status epilepticus. Lancet 1988;1:480-1. (Pubitemid 18067709)
120. Berning S, Boesebeck F, van Baalen A, Kellinghaus C. Intravenous levetiracetam as treatment for status epilepticus. J Neurol 2009;256:1634-42
121. Möddel G, Bunten S, Dobis C, Kovac S, Dogan M, Fischera M, et al. Intravenous levetiracetam: A new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009;80:689-92.
122. Eue S, Grumbt M, Müller M, Schulze A. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav 2009;15:467-9.
123. Tripathi M, Vibha D, Choudhary N, Prasad K, Srivastava MV, Bhatia R, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010;19: 109-11.
124. Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17:348-55.
125. Brandt C, Heile A, Potschka H, Stoehr T, Löscher W. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 2006;47:1803-9. (Pubitemid 44730049)
126. Kellinghaus C, Berning S, Besselmann M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009;14:429-431
127. Tilz C, Resch R, Hofer T, Eggers C. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010;51:316-7.
128. Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ, Byarugaba J. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: A randomized clinical trial. Pediatrics 2008;121:e58-64
129. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34. (Pubitemid 24074462)
130. Misra UK, Kalita J, Nair PP. Status epilepticus in central nervous system infections: an experience from a developing country. Am J Med 2008;121:618-23. (Pubitemid 351876173)
131. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: Role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006;77:611-5. (Pubitemid 43844584)
132. Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003; 61:1066-73. (Pubitemid 37461939)
133. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in aneurological intensive care unit. J Neurol Neurosurg Psychiatry 2005;76:534-9. (Pubitemid 40486579)
134. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1499-50.